In order to obtain this action we must pay 8,14$ right now, Arcutis Biotherapeutics Inc, with address at 2945 TOWNSGATE ROAD SUITE 110, WESTLAKE VILLAGE, California, 91361, United States, is a publicly traded company and its visible heads at the moment are David Berk (Vice President-Clinical Development), David W. Osborne (Chief Technical Officer), Matthew Moore (Chief Business Officer), Patricia A. Turney (Senior Vice President-Operations), Patrick Burnett (Chief Medical Officer), Scott L. Burrows (Chief Financial & Accounting Officer), Todd Franklin Watanabe (President, Chief Executive Officer & Director). Focused on Biotechnology: Pharmaceutical Preparations was created long ago in United States.
Today this action begins with yesterday's closing price, desconocido$.
With an intraday difference of 8,23$ moving between 7,99$ and 8,46$, it is a notable difference that allows quick purchases and sales.
Their latest annual data shows an income of desconocido.
The last value we have registered for the opening is desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
The EPS, or net profit divided by the number of shares in progress, tells us with a high value that we must enter and with a low value that we must leave, it is a result of how the company has done in the last year.
Buscar
